Diabetes Technology: State of the Art

被引:4
作者
Heinemann, Lutz [1 ,2 ,3 ,4 ]
机构
[1] Univ Dusseldorf, Physiol Inst, Dusseldorf, Germany
[2] Univ Dusseldorf, Klin Ernahrung & Stoffwechsel, Dusseldorf, Germany
[3] Stoffwechselforsch GmbH, Profil Inst, Neuss, Germany
[4] Sci Consulting Diabet GmbH, Dusseldorf, Germany
关键词
EUROPEAN ASSOCIATION; INSULIN INJECTIONS; JOINT STATEMENT; WORKING GROUP; TYPE-1; ADULTS; TRIAL; MULTICENTER; PATIENT; SAFETY;
D O I
10.1055/s-0043-124750
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the last decades diabetes technology has developed into an integer part of diabetes therapy. A number of different technologies, most of them are also related to digitalization, are summarized under this heading: Techniques that enable a more accurate and reliable diagnostic approach, i.âŠe. glucose measurement for both, follow-up and diabetes diagnosis. Self-monitoring of capillary blood glucose samples is still a cornerstone of diabetes therapy of most patients with diabetes. It is impressive to see which level of measurement accuracy is possible with modern devices. With a smarter handling of the glucose information collected, i.âŠe. better translation into therapeutic action, improvements in patientÊs overall glucose control and well-being can be achieved. Technological advancements also helped to improve insulin pens and insulin pumps in the last years considerably, especially the development of thin and short needles. Bringing the glucose information with the therapeutic options available in a smart way enables construction of systems that automatically adjust insulin dosing to the individual needs and situation. Artificial pancreas systems will be used most probably by a considerable part of patients with diabetes, depending mainly on the costs involved. Digitalization will massively change the way patients are treated in the future, many decisions will not be made by the diabetologist and his team, but by smart algorithms. Such developments are associated with a number of aspects like data privacy that require careful handling and attention by diabetes medical associations. In summary, diabetes technology represents already an important pillar of diabetes therapy that most probably will gain an even bigger role in the future. ©Georg Thieme Verlag KG, Stuttgart New York.
引用
收藏
页码:329 / 342
页数:14
相关论文
共 23 条
  • [11] Practical Recommendation of the DDG: Glucose Measurement and -Control in Patients with Type-1 or Type-2-Diabetes
    Heinemann, Lutz
    Deiss, Dorothee
    Siegmund, Thorsten
    Schlueter, Sandra
    Naudorf, Michael
    von Sengbusch, Simone
    Lange, Karin
    Freckmann, Guido
    [J]. DIABETOLOGIE UND STOFFWECHSEL, 2017, 12 : S242 - S262
  • [12] Heinemann Lutz, 2016, J Diabetes Sci Technol, V10, P1211
  • [13] Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group
    Heinemann, Lutz
    Fleming, G. Alexander
    Petrie, John R.
    Holl, Reinhard W.
    Bergenstal, Richard M.
    Peters, Anne L.
    [J]. DIABETOLOGIA, 2015, 58 (05) : 862 - 870
  • [14] Heinemann Lutz, 2012, J Diabetes Sci Technol, V6, P954
  • [15] Heinemann Lutz, 2012, J Diabetes Sci Technol, V6, P728
  • [16] DiaDigital Support for Patients and Diabetologists when using Apps
    Kaltheuner, M.
    Drossel, D.
    Heinemann, L.
    [J]. DIABETOLOGE, 2016, 12 (08): : 538 - 549
  • [17] Efficacy of the Telemedical Lifestyle intervention Program TeLiPro in Advanced Stages of Type 2 Diabetes: A Randomized Controlled Trial
    Kempf, Kerstin
    Altpeter, Bernd
    Berger, Janine
    Reuss, Oliver
    Fuchs, Matthias
    Schneider, Michael
    Gaertner, Babette
    Niedermeier, Katja
    Martin, Stephan
    [J]. DIABETES CARE, 2017, 40 (07) : 863 - 871
  • [18] Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial
    Kropff, Jort
    Choudhary, Pratik
    Neupane, Sankalpa
    Barnard, Katharine
    Bain, Steve C.
    Kapitza, Christoph
    Forst, Thomas
    Link, Manuela
    Dehennis, Andrew
    DeVries, J. Hans
    [J]. DIABETES CARE, 2017, 40 (01) : 63 - 68
  • [19] Continous Glucose Monitoring by the Experience of the individual Patient
    Kubiak, T.
    Mann, C. G.
    Heinemann, L.
    [J]. DIABETOLOGIE UND STOFFWECHSEL, 2015, 10 (01) : 29 - 35
  • [20] Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections The GOLD Randomized Clinical Trial
    Lind, Marcus
    Polonsky, William
    Hirsch, Irl B.
    Heise, Tim
    Bolinder, Jan
    Dahlqvist, Sofia
    Schwarz, Erik
    Olafsdottir, Arndis Finna
    Frid, Anders
    Wedel, Hans
    Ahlen, Elsa
    Nystrom, Thomas
    Hellman, Jarl
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (04): : 379 - 387